Akari Therapeutics, Plc Skyrocketed
Thu, May 21, 2026 at 07:49 PM
Akari Therapeutics, Plc (AKTX:NASDAQ) soared at $5.14, a gain of 49.9%. The stock appeared on our News Catalysts scanner on Thu, May 21, 2026 at 07:23 PM in the 'BIOTECH' category. From Thu, May 07, 2026, the stock recorded 50.00% Up Days and 54.55% Green Days
About Akari Therapeutics, Plc (AKTX:NASDAQ)
Akari Therapeutics PLC is a biopharmaceutical company in clinical stage. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system.
Top 10 Gainers:
- Movella Holdings Inc. (MVLA:NASDAQ), 666.67%
- Agape ATP Corporation (ATPC:NASDAQ), 71.77%
- Akanda Corp. (AKAN:NASDAQ), 61.68%
- PicoCELA Inc. (PCLA:NASDAQ), 60.7%
- NewGenIvf Group Limited (NIVF:NASDAQ), 51.54%
- Akari Therapeutics, Plc (AKTX:NASDAQ), 49.85%
- P3 Health Partners Inc. (PIII:NASDAQ), 43.03%
- Falcon's Beyond Global, Inc. (FBYD:NASDAQ), 36.62%
- Everbright Digital Holding Limited (EDHL:NASDAQ), 33.95%
- D-Wave Quantum Inc. (QBTS:NYSE), 33.37%